Navigation Links
Isis Reports Financial Results and Highlights for First Quarter of 2008
Date:5/12/2008

ompany has successfully commercialized the world's first antisense drug and has 18 drugs in development. Isis' drug development programs are focused on treating cardiovascular and metabolic diseases. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Ibis Biosciences, Inc., Isis' majority-owned subsidiary, is developing and commercializing the Ibis T5000(TM) Biosensor System, a revolutionary system to identify infectious organisms. Isis is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development and commercialization of microRNA therapeutics. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,500 issued patents worldwide. Additional information about Isis is available at http://www.isispharm.com.

This press release includes forward-looking statements regarding Isis Pharmaceuticals' business, the financial position and outlook for Isis as well as its Ibis Biosciences subsidiary and its Regulus joint venture, and the therapeutic and commercial potential of the Company's technologies and products in development. Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement, including those statements that are described as Isis' goals or projections. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, in developing and commercializing systems to identify infectious organisms that are effective and commercially attractive, and in the endeavor of building a business around such products. Isis' forward-looking statements also involve assumptions that, if they never materialize or prove
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... PartnerTech Inc. , a major systems integration ... von Uexkull to their facilities, June 6, 2014 as ... a top trade official from the Embassy of Sweden, ... bring awareness and insight to the business community concerning ... , As an expert on global economy, von Uexkull ...
(Date:7/23/2014)... On July 4th, at the age of 70, ... a first place prize in her age group at the Firecracker ... waited until she was in her forties before becoming an ordained ... start running. Not one to do anything halfway, she launched her ... Kitty, the decision to begin running started five years ago at ...
(Date:7/22/2014)... July 22, 2014 Ticket Down ... vs. Manchester City tickets at Sporting Park in Kansas ... on Wednesday, July 23rd. Tickets can be conveniently printed ... Ticket Down can be reached toll free at 1-877-870-3653. ... are authentic and covered by Ticket Down's customer satisfaction guarantee. ...
(Date:7/22/2014)... 23, 2014 Provectus has ... From now on, in addition to working with the ... for Google Glass as well as the creation of ... A dynamic lifestyle requires special gadgets for work, leisure ... found application in healthcare, logistics, travelling, sports, education, science ...
(Date:7/22/2014)... 2014 Obtaining a bachelor’s degree in ... who have hands-on medical experience. The School of Nursing ... announced the launch of an accelerated nursing degree program ... new program, the UNCG Veterans Access Program (VAP), will ... veterans. With some prior college credit, veterans who are ...
Breaking Medicine News(10 mins):Health News:Swedish Official Tours PartnerTech’s U.S. Facility 2Health News:Swedish Official Tours PartnerTech’s U.S. Facility 3Health News:Naperville, Ilinois’ Monarch Landing Resident Wins First Place in 5K Run 2Health News:Sporting Kansas City vs. Manchester City Tickets: Ticket Down Has Slashed Ticket Prices for Manchester City vs. Sporting Kansas City on July 23rd 2Health News:Provectus Announces Development for Google Glass and Wearables 2Health News:UNCG School of Nursing Fast-Tracks Medically Trained Veterans 2
... Epidural hematoma, is a blood clot between the brain and ... Natasha Richardson died from a blunt impact to the head, ... Monday on a beginner,s ski slope in Canada. , The ... hematoma due to blunt impact to the head," said medical ...
... Encourages Dialog between Patients and PhysiciansALEXANDRIA, Va., March 19 ... their end-of-life wishes with their physicians had significantly lower ... found that these conversations between patients and physicians led ... and resulted in a far more peaceful death for ...
... less invasive than deep brain stimulation, researchers say ... with Parkinson,s-like symptoms walked and moved normally again ... frequency electrical currents, a new study shows. , ... has the potential to be an important new ...
... company cofounded by Beth Israel Deaconess Medical Center (BIDMC) ... has announced that it has closed an $8M Series ... Life Sciences (SVLS) and MedImmune Ventures. , The company ... T-cells, with their first program focusing on treatments for ...
... adds features that benefit both patients and health ... a leading international provider of innovative stroke rehabilitation ... www.saebo.com . The new site is designed ... upper extremity stroke rehab products, while making the ...
... of Pittsburgh School of Medicine have begun testing a vaccine ... at high risk for developing the disease. If shown to ... of repeated invasive surveillance tests, such as colonoscopy, that are ... cancer takes years to develop and typically starts with a ...
Cached Medicine News:Health News:Natasha Richardson Died From Head Trauma: Autopsy 2Health News:Natasha Richardson Died From Head Trauma: Autopsy 3Health News:Discussions About End-of-Life Care Reduce Healthcare Costs in Last Week of Life 2Health News:New Parkinson's Treatment Shows Promise in Animals 2Health News:New Parkinson's Treatment Shows Promise in Animals 3Health News:Biotech company cofounded by BIDMC scientists targets natural killer T-cells 2Health News:Saebo Expands Internet Presence With Launch of New Website 2Health News:Saebo Expands Internet Presence With Launch of New Website 3Health News:Pitt vaccine to prevent colon cancer being tested in patients 2
(Date:7/22/2014)... Pa. , July 22, 2014  Eyeon Therapeutics ... dry eye treatment based on a charged hydrophilic polymer ... The product has been shown to be safe and ... Mitchnick , MD, CEO states, "This first set of ... a long way to moving this technology into the ...
(Date:7/22/2014)... , July 22, 2014 Elekta (NSE:EKTAb) and ... that The Christie NHS Foundation Trust ( Manchester, ... a consortium whose mission is to develop the clinical ... radiation therapy system. Such a system would, in principle, ... cancer targets. "The Christie was an ...
(Date:7/22/2014)... SCHOFIELD, Wis. , July 22, 2014 /PRNewswire/ ... and marketer of over-the-counter (OTC) medicinal and healthcare ... corporate sponsor of Operation Troop Aid. ... said Russell Mitchell , CEO and Chairman ... men and women in combat zones experience migraines ...
Breaking Medicine Technology:Particle Sciences and Eyeon Therapeutics Receive Patent on Novel Dry Eye Technology 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 2PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 3
... best value in high performance electronic pipetting!, ... lightweight design reduce hand fatigue and strain ... tip ejector , Color coding for easy ... for greater performance use Hamilton AdvanTip Low ...
... Research pro Electronic Pipette is ideal for ... Its easy-to-follow display, ergonomically-placed operating buttons, and ... reverse pipetting and diluting make this a ... functions of a manual pipette without any ...
... The Research pro Electronic Pipette is ... the laboratory. Its easy-to-follow display, ergonomically-placed operating ... pipetting, dispensing, reverse pipetting and diluting make ... the simple functions of a manual pipette ...
... for Unparalleled Comfort Pick one of our ... Notice the trigger and ejector positionsright where they ... pipettors are ergonomically designed to help avoid repetitive ... Productivity In The Palm Of Your Hand ...
Medicine Products: